A citation-based method for searching scientific literature

W D Dupont, D L Page. N Engl J Med 1985
Times Cited: 1409







List of co-cited articles
522 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Benign breast disease and the risk of breast cancer.
Lynn C Hartmann, Thomas A Sellers, Marlene H Frost, Wilma L Lingle, Amy C Degnim, Karthik Ghosh, Robert A Vierkant, Shaun D Maloney, V Shane Pankratz, David W Hillman,[...]. N Engl J Med 2005
518
47

Atypical hyperplasia of the breast--risk assessment and management options.
Lynn C Hartmann, Amy C Degnim, Richard J Santen, William D Dupont, Karthik Ghosh. N Engl J Med 2015
165
20

Atypical hyperplastic lesions of the female breast. A long-term follow-up study.
D L Page, W D Dupont, L W Rogers, M S Rados. Cancer 1985
741
19

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
14

Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.
Lynn C Hartmann, Derek C Radisky, Marlene H Frost, Richard J Santen, Robert A Vierkant, Lorelle L Benetti, Yaman Tarabishy, Karthik Ghosh, Daniel W Visscher, Amy C Degnim. Cancer Prev Res (Phila) 2014
110
13

Benign breast diseases: classification, diagnosis, and management.
Merih Guray, Aysegul A Sahin. Oncologist 2006
132
13

Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.
Jeffrey A Tice, Diana L Miglioretti, Chin-Shang Li, Celine M Vachon, Charlotte C Gard, Karla Kerlikowske. J Clin Oncol 2015
122
13

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
12

Breast cancer risk associated with benign breast disease: systematic review and meta-analysis.
Sara W Dyrstad, Yan Yan, Amy M Fowler, Graham A Colditz. Breast Cancer Res Treat 2015
70
17

Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
Amy C Degnim, Daniel W Visscher, Hal K Berman, Marlene H Frost, Thomas A Sellers, Robert A Vierkant, Shaun D Maloney, V Shane Pankratz, Piet C de Groen, Wilma L Lingle,[...]. J Clin Oncol 2007
154
12

Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study.
David L Page, Peggy A Schuyler, William D Dupont, Roy A Jensen, W Dale Plummer, Jean F Simpson. Lancet 2003
199
11

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
Jeffrey A Tice, Steven R Cummings, Rebecca Smith-Bindman, Laura Ichikawa, William E Barlow, Karla Kerlikowske. Ann Intern Med 2008
352
11

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.
W D Dupont, F F Parl, W H Hartmann, L A Brinton, A C Winfield, J A Worrell, P A Schuyler, W D Plummer. Cancer 1993
350
10

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. Cancer Prev Res (Phila) 2010
398
10

Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.
Amy C Degnim, William D Dupont, Derek C Radisky, Robert A Vierkant, Ryan D Frank, Marlene H Frost, Stacey J Winham, Melinda E Sanders, Jeffrey R Smith, David L Page,[...]. Cancer 2016
30
30

Exemestane for breast-cancer prevention in postmenopausal women.
Paul E Goss, James N Ingle, José E Alés-Martínez, Angela M Cheung, Rowan T Chlebowski, Jean Wactawski-Wende, Anne McTiernan, John Robbins, Karen C Johnson, Lisa W Martin,[...]. N Engl J Med 2011
580
9

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
699
9

Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis.
Valerie A McCormack, Isabel dos Santos Silva. Cancer Epidemiol Biomarkers Prev 2006
9

A prospective study of benign breast disease and the risk of breast cancer.
S J London, J L Connolly, S J Schnitt, G A Colditz. JAMA 1992
354
8

Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy.
Tehillah S Menes, Karla Kerlikowske, Jane Lange, Shabnam Jaffer, Robert Rosenberg, Diana L Miglioretti. JAMA Oncol 2017
28
28


Benign breast disorders.
Richard J Santen, Robert Mansel. N Engl J Med 2005
136
8

The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions.
Suzanne B Coopey, Emanuele Mazzola, Julliette M Buckley, John Sharko, Ahmet K Belli, Elizabeth M H Kim, Fernanda Polubriaginof, Giovanni Parmigiani, Judy E Garber, Barbara L Smith,[...]. Breast Cancer Res Treat 2012
75
10

Current management of lesions associated with an increased risk of breast cancer.
Monica Morrow, Stuart J Schnitt, Larry Norton. Nat Rev Clin Oncol 2015
64
10

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Bernard Fisher, Joseph P Costantino, D Lawrence Wickerham, Reena S Cecchini, Walter M Cronin, Andre Robidoux, Therese B Bevers, Maureen T Kavanah, James N Atkins, Richard G Margolese,[...]. J Natl Cancer Inst 2005
854
7


A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer.
Geoffrey C Kabat, Joan G Jones, Neal Olson, Abdissa Negassa, Catherine Duggan, Mindy Ginsberg, Rita A Kandel, Andrew G Glass, Thomas E Rohan. Cancer Causes Control 2010
62
11

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
7

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Jack Cuzick, Ivana Sestak, John F Forbes, Mitch Dowsett, Jill Knox, Simon Cawthorn, Christobel Saunders, Nicola Roche, Robert E Mansel, Gunter von Minckwitz,[...]. Lancet 2014
353
7

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
Debra L Monticciolo, Mary S Newell, Linda Moy, Bethany Niell, Barbara Monsees, Edward A Sickles. J Am Coll Radiol 2018
253
7

The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
Laura C Collins, Heather J Baer, Rulla M Tamimi, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2006
48
14

Lower-category benign breast disease and the risk of invasive breast cancer.
Jiping Wang, Joseph P Costantino, Elizabeth Tan-Chiu, D Lawrence Wickerham, Soonmyung Paik, Norman Wolmark. J Natl Cancer Inst 2004
61
11

Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study.
Laura C Collins, Heather J Baer, Rulla M Tamimi, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2007
92
6

Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.
Daniel W Visscher, Marlene H Frost, Lynn C Hartmann, Ryan D Frank, Robert A Vierkant, Ann E McCullough, Stacey J Winham, Celine M Vachon, Karthik Ghosh, Kathleen R Brandt,[...]. Cancer 2016
20
30

European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document.
N Perry, M Broeders, C de Wolf, S Törnberg, R Holland, L von Karsa. Ann Oncol 2008
448
6


Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.
Jack Cuzick, Ivana Sestak, Simon Cawthorn, Hisham Hamed, Kaija Holli, Anthony Howell, John F Forbes. Lancet Oncol 2015
247
6


Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies.
Laura C Collins, Sarah A Aroner, James L Connolly, Graham A Colditz, Stuart J Schnitt, Rulla M Tamimi. Cancer 2016
33
15

Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.
Tari A King, Melissa Pilewskie, Shirin Muhsen, Sujata Patil, Starr K Mautner, Anna Park, Sabine Oskar, Elena Guerini-Rocco, Camilla Boafo, Jessica C Gooch,[...]. J Clin Oncol 2015
96
5

Diagnostic concordance among pathologists interpreting breast biopsy specimens.
Joann G Elmore, Gary M Longton, Patricia A Carney, Berta M Geller, Tracy Onega, Anna N A Tosteson, Heidi D Nelson, Margaret S Pepe, Kimberly H Allison, Stuart J Schnitt,[...]. JAMA 2015
253
5

Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium.
Tehillah S Menes, Robert Rosenberg, Steven Balch, Shabnam Jaffer, Karla Kerlikowske, Diana L Miglioretti. Am J Surg 2014
48
10

Long-term risk of breast cancer in women with fibroadenoma.
W D Dupont, D L Page, F F Parl, C L Vnencak-Jones, W D Plummer, M S Rados, P A Schuyler. N Engl J Med 1994
273
5


Genome evolution during progression to breast cancer.
Daniel E Newburger, Dorna Kashef-Haghighi, Ziming Weng, Raheleh Salari, Robert T Sweeney, Alayne L Brunner, Shirley X Zhu, Xiangqian Guo, Sushama Varma, Megan L Troxell,[...]. Genome Res 2013
77
6

Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
Kala Visvanathan, Patricia Hurley, Elissa Bantug, Powel Brown, Nananda F Col, Jack Cuzick, Nancy E Davidson, Andrea Decensi, Carol Fabian, Leslie Ford,[...]. J Clin Oncol 2013
209
5

The molecular pathology of breast cancer progression.
Alessandro Bombonati, Dennis C Sgroi. J Pathol 2011
223
5

Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.
Ester Vilaprinyo, Carles Forné, Misericordia Carles, Maria Sala, Roger Pla, Xavier Castells, Laia Domingo, Montserrat Rue. PLoS One 2014
90
5

Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program.
Xavier Castells, Laia Domingo, Josep María Corominas, Isabel Torá-Rocamora, María Jesús Quintana, Marisa Baré, Carmen Vidal, Carmen Natal, Mar Sánchez, Francina Saladié,[...]. Breast Cancer Res Treat 2015
28
17

A prospective study of the development of breast cancer in 16,692 women with benign breast disease.
C L Carter, D K Corle, M S Micozzi, A Schatzkin, P R Taylor. Am J Epidemiol 1988
269
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.